Background Dyslipidemia is a major risk factor for ischemic heart disease in the world. The last updated ACC/AHA and ESC/EAS guidelines for dyslipidemia management aimed to control blood cholesterol and reduce cardiovascular risk. In Jordan, no national guidelines have been published to date, so these guidelines are commonly used. There are a few studies exploring the implementation of these guidelines in Jordan.

purpose To explore the implementation of updated ACC/AHA and ESC/EAS guidelines for the treatment and care of dyslipidemia among nurses and physicians in Jordan.

Method Semi-structured interviews (three focus group) with open-ended questions was conducted to gain deeper understanding of implemented practice and guidelines among nurses and physicians.

Results Focus group interviews revealed that health care professionals try to implement specific guidelines and reach for optimal goals, but many barriers prevent them from reaching therapeutic goals, like workload, limited resources, and a lack of support from health institutions. They reported many suggestions that may enhance their ability to implement dyslipidemia management guidelines and wanted to improve specific guidelines in Jordan for dyslipidemia management.

Conclusions Results indicated limited implementation of any dyslipidemia management guidelines among Jordanian nurses and physicians in their clinical practices.

The authors have declared no competing interest.

Yes

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The research described in this manuscript was approved by the committee of scientific research and ethics of research at faculty of nursing/AL al-Bayt University

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All relevant data are within the manuscript and its Supporting Information files.